Precigen, Inc. (PGEN)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Precigen, Inc. keeps $37 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 12
in 18 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Precigen’s results for the second fiscal quarter of 2026 pointed to cash outflow and a small share repurchase, with next-period consensus calling for EPS of $0.09 on revenue of $69.2 million; the company reported the quarter on August 4, 2026. During the period, operating cash flow was negative at roughly $17.8 million, reflecting a net cash use from operations. The company also repurchased about $1.5 million of stock. Precigen operates across human therapeutics and enabling technologies, including platforms such as UltraVector, RheoSwitch, and ActoBiotics, alongside regenerative-medicine and reproductive-tool offerings such as genetically engineered swine and reproductive and embryo transfer technologies.
Next report — what to expect
Precigen, Inc. (PGEN) is set to report earnings on November 12, 2026. With consensus EPS and revenue not available here, the main preprint focus is on any updates around its pipeline and commercialization progress. Historically, Precigen has beaten EPS in 4 of its 8 most recent quarters.
About Precigen, Inc.
Precigen, Inc. is a small-cap Biotechnology company listed on the NASDAQ under the ticker PGEN. The company develops disease-modifying treatments and applies its platform technologies to regenerative medicine and reproductive tools, with operations rooted in a business founded in 1998 and based in Germantown, Maryland.
Today's Snapshot
PGEN closed 3.1% lower at 6.19, in line with a weaker sector.
Trading Volume
Below 10d avg (4.5M)
4.1M
vs S&P 500 Today
Underperforming Market
-2.61%
Updated: October 23, 2026 at 20:11 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$5.56 - $7.09Sell
- RSI (14)34.60Neutral
- Stochastic %K (14, 3, 3)6.56Buy
- MACD Level (12, 26)-0.26Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.